What is Viridian Therapeutics, Inc.'s other working capital?

Viridian Therapeutics, Inc. (VRDN) reported other working capital of -$169K in Q1 2026.

How has Viridian Therapeutics, Inc.'s other working capital changed year-over-year?

Viridian Therapeutics, Inc.'s other working capital decreased by 2916.7% year-over-year, from $6K to -$169K.

What does other working capital mean?

Net change in working capital items not separately classified — a residual balancing item.

Viridian Therapeutics, Inc. VRDN Other Working Capital

Other Working Capital at other companies

AmgenAMGN

$67M+34.0%

Ultragenyx PharmaceuticalRARE

-$1M-200%

Krystal Biotech, Inc.KRYS

$136K-77.9%

Arrowhead ResearchARWR

-$385K+78.2%

BridgeBio PharmaBBIO

-$306K-1,557%

Roivant SciencesROIV

-$8.3M-230%

Other financials

Income statement

See full

Revenue$141.0K+95.8%

Operating income-$116.2M-23.8%

Net income-$104.9M-20.7%

EPS (diluted)-$1.15-5.5%

Balance sheet

See full

Cash & equivalents$176.3M+51.7%

Total debt$36.8M+59.4%

Total equity$636.0M+5.2%

Total assets$789.0M+19.4%

Cash flow

See full

Operating cash flow-$119.7M-29.1%

CapEx$23.0K-73.3%

Free cash flow-$119.7M-29.0%

Valuation

See full

Market cap$1.91B+82.0%

Enterprise value$1.77B+85.0%

P/S26.9×-3,445×

Profitability

See full

Gross margin36.3%—

Operating margin-543.9%-271pp

Net margin-508.5%-254pp

FCF margin-428.4%-214pp

Returns & leverage

See full

Return on equity-58.1%+7.9pp

Debt / equity0.1×0.0×

Current ratio15.1×-4.3×

Where this comes from

Reported directly by Viridian Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Viridian Therapeutics, Inc.'s other working capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Viridian Therapeutics, Inc.'s other working capital?: Viridian Therapeutics, Inc. (VRDN) reported other working capital of -$169K in Q1 2026.
How has Viridian Therapeutics, Inc.'s other working capital changed year-over-year?: Viridian Therapeutics, Inc.'s other working capital decreased by 2916.7% year-over-year, from $6K to -$169K.
What does other working capital mean?: Net change in working capital items not separately classified — a residual balancing item.